BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Laser capture microdissection
,
Valproic acid
,
rs2230926
,
PDX1
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
folate receptor- α
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for folate receptor- α
Explore Curated Studies Results
Literature
Most Relevant Literature
Expression of folate receptor-α (FRA) in gynecologic malignancies and its relationship to the tumor …
Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor…
Nuclear localization of folate receptor alpha: a new role as a transcription factor.
Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha.
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting:…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometri…
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, …
A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cel…
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant…
ITIL-306 in Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ